Literature DB >> 26627491

Long-Term Outcomes of Obesity Surgery and Implications for Health System Planning.

James Charles Hopkins1, Richard Welbourn2.   

Abstract

Weight loss surgery is currently the only treatment that offers significant and sustained weight loss for those with severe and complex obesity. Obesity levels have reached a sustained high, whereby several percent of a country's population would qualify for surgery based upon current national guidelines. Worldwide, the provision of surgery is highly variable and to treat all the affected population, it would require at least a 100-fold increase in the provision of services. This has important cost and commissioning implications for health-care planners. Reliable level 1 evidence of the long-term effects of obesity surgery is still lacking, and the long-term complication profiles and re-operation rates unclear, which could have significant impact on health-care systems in the future. The chronic disease management of obesity in a population must be integrated with education and prevention and the brief intervention of weight loss surgery and the management of its sequelae, to prevent significant future morbidity and mortality.

Entities:  

Keywords:  Bariatric surgery implications for health planning; Long-term obesity outcomes

Mesh:

Year:  2015        PMID: 26627491     DOI: 10.1007/s13679-015-0165-8

Source DB:  PubMed          Journal:  Curr Obes Rep        ISSN: 2162-4968


  46 in total

Review 1.  Weight recidivism post-bariatric surgery: a systematic review.

Authors:  Shahzeer Karmali; Balpreet Brar; Xinzhe Shi; Arya M Sharma; Christopher de Gara; Daniel W Birch
Journal:  Obes Surg       Date:  2013-11       Impact factor: 4.129

2.  Laparoscopic Roux-en-Y gastric bypass: 10-year follow-up.

Authors:  Kelvin Higa; Tienchin Ho; Francisco Tercero; Tahir Yunus; Keith B Boone
Journal:  Surg Obes Relat Dis       Date:  2010-11-26       Impact factor: 4.734

3.  Why Bariatric surgery should be given high priority: an argument from law and morality.

Authors:  Karl Persson
Journal:  Health Care Anal       Date:  2014-12

4.  Global estimates of diabetes prevalence for 2013 and projections for 2035.

Authors:  L Guariguata; D R Whiting; I Hambleton; J Beagley; U Linnenkamp; J E Shaw
Journal:  Diabetes Res Clin Pract       Date:  2013-12-01       Impact factor: 5.602

Review 5.  Long-term outcomes after bariatric surgery: fifteen-year follow-up of adjustable gastric banding and a systematic review of the bariatric surgical literature.

Authors:  Paul E O'Brien; Leah MacDonald; Margaret Anderson; Leah Brennan; Wendy A Brown
Journal:  Ann Surg       Date:  2013-01       Impact factor: 12.969

6.  Health care use during 20 years following bariatric surgery.

Authors:  Martin Neovius; Kristina Narbro; Catherine Keating; Markku Peltonen; Kajsa Sjöholm; Göran Agren; Lars Sjöström; Lena Carlsson
Journal:  JAMA       Date:  2012-09-19       Impact factor: 56.272

7.  Bariatric surgery and prevention of type 2 diabetes in Swedish obese subjects.

Authors:  Lena M S Carlsson; Markku Peltonen; Sofie Ahlin; Åsa Anveden; Claude Bouchard; Björn Carlsson; Peter Jacobson; Hans Lönroth; Cristina Maglio; Ingmar Näslund; Carlo Pirazzi; Stefano Romeo; Kajsa Sjöholm; Elisabeth Sjöström; Hans Wedel; Per-Arne Svensson; Lars Sjöström
Journal:  N Engl J Med       Date:  2012-08-23       Impact factor: 91.245

Review 8.  The economic impact of weight regain.

Authors:  Caroline E Sheppard; Erica L W Lester; Anderson W Chuck; Daniel W Birch; Shahzeer Karmali; Christopher J de Gara
Journal:  Gastroenterol Res Pract       Date:  2013-12-26       Impact factor: 2.260

9.  The cost-effectiveness of laparoscopic adjustable gastric banding in the morbidly obese adult population of Australia.

Authors:  Yong Yi Lee; J Lennert Veerman; Jan J Barendregt
Journal:  PLoS One       Date:  2013-05-22       Impact factor: 3.240

10.  The By-Band study: gastric bypass or adjustable gastric band surgery to treat morbid obesity: study protocol for a multi-centre randomised controlled trial with an internal pilot phase.

Authors:  Chris A Rogers; Richard Welbourn; James Byrne; Jenny L Donovan; Barnaby C Reeves; Sarah Wordsworth; Robert Andrews; Janice L Thompson; Paul Roderick; David Mahon; Hamish Noble; Jamie Kelly; Graziella Mazza; Katie Pike; Sangeetha Paramasivan; Natalie Blencowe; Mary Perkins; Tanya Porter; Jane M Blazeby
Journal:  Trials       Date:  2014-02-11       Impact factor: 2.279

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.